Skip to main content

Percutaneous Transluminal Septal Myocardial Ablation and Common Procedural Complications Before and After the Approval of Ablysinol

    Basic Details
    Date
    Sunday, August 27, 2023
    Type
    Presentation
    Description

    This poster examines the frequency of percutaneous transluminal septal myocardial ablation (PTSMA) and common procedural complications before and after approval of Ablysinol using the FDA Sentinel System. It was presented at the 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. 

    Presenter(s)

    Marie C. Bradley